Similar articles for PMID: 25340724

Year	Number of Results
1990	1
1997	4
1998	2
1999	1
2000	7
2001	3
2002	9
2003	3
2004	16
2005	9
2006	6
2007	4
2008	5
2009	7
2010	8
2011	5
2012	2
2013	2
2014	2
2015	3
2016	6
2017	4
2018	1
2021	3
2022	4
2024	0

1

Clozapine augmentation with amisulpride.

Porcelli S, Serretti A, Bianchini O. Porcelli S, et al. J Psychiatry Neurosci. 2014 Nov;39(6):E38-9. doi: 10.1503/jpn.140094. J Psychiatry Neurosci. 2014. PMID: 25340724 Free PMC article. No abstract available.

2

Amisulpride augmentation of clozapine in refractory schizophrenia.

Chiu HW, Ku YC, Li TC, Huang HT. Chiu HW, et al. J Neuropsychiatry Clin Neurosci. 2011 Summer;23(3):E15. doi: 10.1176/jnp.23.3.jnpe15. J Neuropsychiatry Clin Neurosci. 2011. PMID: 21948906 No abstract available.

3

Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.

Kämpf P, Agelink MW, Naber D. Kämpf P, et al. Pharmacopsychiatry. 2005 Jan;38(1):39-40. doi: 10.1055/s-2005-837772. Pharmacopsychiatry. 2005. PMID: 15706467 No abstract available.

4

Effectiveness of amisulpride augmentation of clozapine in a non-responder to either drug alone: a case report.

George S, Cowan C. George S, et al. Acta Psychiatr Scand. 2005 Feb;111(2):163. doi: 10.1111/j.1600-0447.2004.00484.x. Acta Psychiatr Scand. 2005. PMID: 15667440 No abstract available.

5

Clozapine with amisulpride for refractory schizophrenia.

Agelink MW, Kavuk I, Ak I. Agelink MW, et al. Am J Psychiatry. 2004 May;161(5):924-5. doi: 10.1176/appi.ajp.161.5.924-a. Am J Psychiatry. 2004. PMID: 15121665 Clinical Trial. No abstract available.

6

Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.

Barnes TR, Leeson VC, Paton C, Marston L, Davies L, Whittaker W, Osborn D, Kumar R, Keown P, Zafar R, Iqbal K, Singh V, Fridrich P, Fitzgerald Z, Bagalkote H, Haddad PM, Husni M, Amos T. Barnes TR, et al. Health Technol Assess. 2017 Sep;21(49):1-56. doi: 10.3310/hta21490. Health Technol Assess. 2017. PMID: 28869006 Free PMC article. Clinical Trial.

7

Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.

Munro J, Matthiasson P, Osborne S, Travis M, Purcell S, Cobb AM, Launer M, Beer MD, Kerwin R. Munro J, et al. Acta Psychiatr Scand. 2004 Oct;110(4):292-8. doi: 10.1111/j.1600-0447.2004.00356.x. Acta Psychiatr Scand. 2004. PMID: 15352931 Clinical Trial.

8

Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.

Assion HJ, Reinbold H, Lemanski S, Basilowski M, Juckel G. Assion HJ, et al. Pharmacopsychiatry. 2008 Jan;41(1):24-8. doi: 10.1055/s-2007-993209. Pharmacopsychiatry. 2008. PMID: 18203048 Clinical Trial.

9

Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study.

Genç Y, Taner E, Candansayar S. Genç Y, et al. Adv Ther. 2007 Jan-Feb;24(1):1-13. doi: 10.1007/BF02849987. Adv Ther. 2007. PMID: 17526456 Clinical Trial.

10

Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study.

Kreinin A, Novitski D, Weizman A. Kreinin A, et al. Int Clin Psychopharmacol. 2006 Mar;21(2):99-103. doi: 10.1097/01.yic.0000188216.92408.69. Int Clin Psychopharmacol. 2006. PMID: 16421461 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year